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Abstract  
The purpose of the study was to examine whether a higher aerobic 
fitness in 9-10 year old children is related to superior macro and 
microvascular health and cardiovascular disease (CVD) risk. 
Ninety-six 9-10 year olds (53 boys) completed the study. Body 
composition was assessed from air displacement 
plethysmography and magnetic resonance imaging. Peak oxygen 
uptake (V̇O2) was assessed from a ramp-incremental cycling 
exercise test. Macrovascular outcomes were assessed from pulse 
wave analysis and pulse wave velocity (PWV) using applanation 
tonometry. Microvascular function was assessed from the 
functional microvascular reserve and skin erythrocyte flux after 
iontophoretic application of skin vasodilators. Assessment of 
CVD risk was assessed via body mass index, total body fat 
percentage and visceral adipose tissue, glucose, triglyceride, total 
cholesterol, HDL cholesterol and LDL cholesterol, while insulin 
resistance was calculated using Homeostatic model assessment. 
Aerobic fitness groups (higher vs lower) were calculated from 
V̇O2 peak scaled for body mass (mLꞏkg-0.61ꞏmin-1) and fat free 
mass (mLꞏFFM-1ꞏmin-1). Children with a higher V̇O2 peak scaled 
for body mass had a greater carotid to ankle PWV compared to 
those with lower aerobic fitness (mean ± SD: 6.08 ± 0.47 vs. 5.87 
± 0.43 mꞏs-1; p = 0.039), although this became non-significant 
when scaled for FFM (p  = 0.56). No other mean differences in 
vascular or CVD risk health markers were present between higher 
and lower groups of aerobic fitness when scaled for body mass or 
FFM. Conclusion: Directly assessed aerobic fitness is not related 
to macro and microvascular health outcomes or CVD risk 
markers in 9-10 year olds.  
 
Key words: Peak oxygen uptake, heart disease, youth, blood 
vessel.
  
Introduction 
 
Cardiovascular diseases (CVD) are the leading causes of 
non-communicable deaths worldwide (WHO, 2018). 
Although the consequences of CVD, such as a myocardial 
infarction or stroke, do not manifest until adulthood, the 
pathobiology of CVD begins in childhood (Juonala et al., 
2005). The atherosclerotic process is progressive and is 
associated with the development of CVD risk factors 
during childhood as well as early deterioration in vascular 
function (Aggoun et al., 2005). Promoting cardiovascular 
health in childhood and identifying those with elevated risk 
is therefore important for the prevention of CVD outcomes 
in adulthood (Urbina et al., 2009).  
Aerobic fitness is a strong predictor of 
cardiovascular health with low aerobic fitness being 
associated with elevated CVD risk in children and 
adolescents (Barker et al., 2018; Ekelund et al., 2007; 
Steele et al., 2008). Conversely, a high level of aerobic 
fitness has been associated with lower blood pressure 
(Nielsen and Andersen, 2003), improved lipid profiles 
(Hager et al., 1995), lower levels of inflammatory markers 
(Isasi et al., 2003), lower rates of obesity (Janz et al., 2002) 
and enhanced insulin sensitivity (Lee et al., 2006) in 
children and adolescents. More recently, aerobic fitness 
during adolescence has also been found to relate to 
myocardial infarction (Högström et al., 2014) and 
mortality (Högström et al., 2016) in adult life. These data 
suggest a possible protective effect of attaining high levels 
of aerobic fitness within youth upon CVD risk factors and 
vascular and haemodynamic function. 
Exercise training has been shown to enhance both 
macro and microvascular function in adults (Green et al., 
2011) and adolescents (Bond et al., 2015). Data in healthy 
children are sparse, but an association between aerobic 
fitness and macrovascular function has been shown in 6 to 
11 year old children (Agbaje et al., 2019; Hopkins et al., 
2009; Reed et al., 2005; Veijalainen et al., 2016). Sakuragi 
and colleagues (2009) also reported a negative association 
between aerobic fitness and arterial stiffness in 573 10-year 
olds, although the association became weaker after 
adjusting for adiposity. Aerobic fitness was assessed 
indirectly using the 20 m shuttle run test, which although 
correlates with a direct measurement of peak oxygen 
uptake (V̇O2 peak) in children (Castro-Pinero et al., 2010), 
the explained variance can be less than 50%  (Mayorga-
Vega et al., 2015). Furthermore, the test is strongly 
influenced by adiposity (Olds and Dollman, 2004) and has 
been criticised for being a measure of performance and 
thereby its use as a prediction for estimating peak V̇O2 has 
been questioned (Armstrong, 2018). Thus, the 
recommended ‘gold-standard’ measurement of aerobic 
fitness requires gas analysis during maximal exercise to 
directly measure V̇O2 peak (Barker et al., 2013) with 
adjustment for body size and composition (Loftin et al., 
2016). Nadeau and colleagues (2010) directly measured 
V̇O2 peak and reported a positive correlation with forearm 
blood flow in healthy adolescents and adolescents with 
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type I diabetes. Although the group directly measured V̇O2 
peak, it was expressed as a ratio-standard for body mass 
(mL.kg-1.min-1) which may not adequately control for body 
size (Welsman and Armstrong, 2000). Allometric scaling 
methods are recommended to control for the influence of 
body size on aerobic capacity and have been shown to 
reduce the size of the relationship between aerobic fitness 
and markers of CVD risk in children when compared to the 
ratio standard method and after accounting for body 
composition (Agbaje et al., 2019). 
Microvascular dysfunction is an important predictor 
of early atherosclerosis (Wilkins et al., 2012) and provides 
additional valuable information on vascular risk. However, 
our understanding of the relationship with fitness and 
microvascular function in paediatric groups is limited. 
There is evidence to suggest more physically active 
children have better retinal arteriolar caliber (Gopinath et 
al., 2011) but not microvascular function (Radtke et al., 
2013). Reed and colleagues (2005) identified that healthy 
children with higher levels of aerobic fitness had improved 
small vessel function, although only arterial stiffness was 
assessed and V̇O2 peak was estimated from the 20 m shuttle 
run test. Paediatric analyses of microvascular function 
have typically included overweight or obese children 
(representing > 50% of the sample) (Bastos da Cunha et al., 
2017; Hedvall Kallerman et al., 2014) or those with type I 
diabetes (Roche et al., 2008). Furthermore, studies that 
have focused on the association between microcirculatory 
function and aerobic fitness typically use a single measure 
of vascular function (Reed et al., 2005) or quantify aerobic 
fitness using the ratio standard expression for V̇O2 peak 
without appropriate statistical justification (Roche et al., 
2008). 
The aim of this study was to examine differences in 
macro and microvascular function between 9-10 year old 
children stratified for ‘higher’ and ‘lower’ directly assessed 
aerobic fitness (i.e. V̇O2 peak) with appropriate adjustment 
for body size and composition. We also explored 
differences in CVD risk factors and blood markers 
including insulin resistance between levels of aerobic 
fitness. We hypothesised that: 1) children with higher 
aerobic fitness will have superior macro and microvascular 
function in comparison to those with lower aerobic fitness, 
even after adjusting for adiposity and 2) children with 
lower aerobic fitness will have a poorer CVD risk factor 
profile including increased insulin resistance compared to 
those with higher aerobic fitness. 
  
Methods 
 
Participants 
Children from three state primary schools in the South 
West of England were invited to participate in the study 
and 100 children (53 males, 47 females) aged nine and 10 
years volunteered. One girl withdrew following her initial 
visit and three girls were removed from the study due to 
use of vasoactive medication leaving a total sample of 96 
children (53 males, 43 females). Written informed assent 
and consent was obtained from the child and their 
parents/guardians respectively. A medical screening 
questionnaire  was  completed  and  signed  by  the parents/  
guardians.  The  Local  Medical   Research  Ethics 
Committee provided ethical approval for the study.  
The children visited the University laboratories on 
three occasions over a 1-month period where practical. 
During the first visit anthropometric measures and body 
composition were assessed. During the second visit a 
maximal exercise test was completed and during the third 
visit vascular function and blood markers were assessed.  
 
Anthropometry  
Measurements were performed while the child was 
wearing either a lightweight t-shirt and shorts or a 
swimming costume with no footwear. Stature was 
measured using a stadiometer to the nearest 0.01 m.  Body 
mass was assessed with a balance beam scale and recorded 
to the nearest 0.1 kg. Body mass index (BMI) was 
calculated. Children were classified as lean, overweight or 
obese using age and sex-specific BMI cut-offs (Cole et al., 
2000). 
Total body fat percentage (TBF%) was calculated 
following air displacement plethysmography (BOD POD 
2000A). Body volume was adjusted for lung volume using 
tidal volume estimates. TBF% was calculated from body 
density using Lohman’s child adjusted Siri equation 
(Lohman, 1989). TBF% was obtained in 86 of the 
participants and subsequently used to estimate fat free mass 
(FFM). 
Visceral adipose tissue (VAT) was assessed using 
magnetic resonance imaging. Examinations were 
performed using a 1.5 Tesla superconducting magnetic 
resonance scanner (Gyroscan Intera, Philips). Interleaved 
transverse slices (8 mm thick, with a 1 mm gap between 
them) were acquired from lumbar region (L)1 to L5 with a 
typical voxel size of 2.5 x 3.5 x 8.0 mm. Scanning was 
performed with the participant performing a ~ 20 s breath 
hold to minimize movement artifacts. Data are reported for 
86 children for whom successful scans were obtained. The 
estimated volumes for VAT and the total cavity from L1 to 
L5 in cm3 were determined.  
 
Aerobic fitness 
Peak V̇O2 was determined during a ramp exercise test to 
volitional exhaustion on an electro-magnetically braked 
cycle ergometer (Excaliber Sport; Lode). Heart rate (HR) 
was measured continuously using HR telemetry (Polar 
Vantage NV, Polar Electro Oy). Gas exchange variables 
(e.g. V̇O2), were measured continuously using an online 
breath-by-breath metabolic cart (Cortex Metalyzer 3B; 
Cortex Medical) which was calibrated prior to each test. 
The test began with a 5-minute warm up at 20 watts (W), 
followed by a 10 W increment per minute protocol until 
voluntary exhaustion, despite strong verbal 
encouragement. Participants were asked to maintain a 
pedal cadence of ~ 70 rpm throughout the test. Peak V̇O2 
was taken as the highest 10 s average V̇O2 during the test, 
which in our laboratory results in the measurement of a true 
maximal V̇O2 in ~ 90% of cases (Barker et al., 2011; 
Sansum et al., 2019). Absolute peak V̇O2 (Lꞏmin-1) was 
initially ratio scaled to body mass (mLꞏkg-1ꞏmin-1) and 
FFM (mLꞏkg FFM-1ꞏmin-1). Preliminary analyses revealed 
a significant residual size correlation for ratio scaling of 
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body mass (r = -0.40; p < 0.001), demonstrating the 
invalidity of this method. Therefore, a log-linear allometric 
model controlling for sex (Welsman and Armstrong, 
2000), was used to identify a scaling exponent (b = 0.61) 
for body mass. This exponent was subsequently used for 
both sexes to allometrically scale peak V̇O2 via the power 
function ratio (mLꞏkg-0.61ꞏmin-1), which no longer 
correlated with body mass (r = -0.06; p = 0.58). In contrast, 
as ratio scaling of peak V̇O2 with FFM satisfied the 
statistical assumptions underlying ratio scaling (Welsman 
and Armstrong, 2019), allometric scaling was not required 
in this case. 
 
Vascular function 
Vascular function was assessed in the morning following 
an overnight fast and conducted in a quiet, temperature-
controlled room (22.0 ± 0.5 °C) with the child lying in the 
supine position following an acclimatisation period of 30 
minutes.  
 
Pulse wave analysis 
Applanation tonometry of the radial pulse of the right arm 
enabled analysis of the peripheral waveforms. A high-
fidelity micromanometer (SphygmoCor®; AtCor Medical 
Pty. Ltd., Sydney, Australia) was used to flatten, but not 
occlude, the radial artery using gentle pressure. The 
waveforms were visually displayed on a portable 
microcomputer using online recording software 
(SphygmoCor® version 7.01; AtCor Medical Pty. Ltd., 
Sydney, Australia). A three-lead electrocardiogram (ECG) 
incorporated within the SphygmoCor® software displayed 
ECG waveforms alongside peripheral waveforms 
simultaneously and enabled the R wave peak to be used as 
a reference point. After two sequential screens of clear 
waveforms (using all complete and satisfactory complexes 
within a 10 second period), the averaged peripheral and 
corresponding central arterial waveform were recorded. 
Measures were taken in triplicate and the mean value used. 
The resulting augmentation index (AI) was assessed as the 
size of the reflected peak with respect to the primary peak. 
Since the transformation of pulse wave analysis using 
central pressures has not been validated in children under 
the age of 17 years (Khan et al., 2006), the peripheral non-
transformed index (PAI) was used. The intra-individual 
coefficient of variation (CV) of PAI in our laboratory is 
8.5%.  
 
Pulse wave velocity (PWV) 
To determine PWV, pressure waveforms were recorded at 
two sites sequentially: carotid to radial for brachial PWV 
and carotid to posterior tibial (ankle) for aortic PWV. We 
chose to use the posterior tibial rather than the femoral 
artery because of potential embarrassment for the 
participants, leading to measurement refusal. Although less 
commonly used than the femoral site, the tibial site has 
previously been used in the assessment of PWV in pre-
school aged children (Currie et al., 2010).  Distances 
between the radial and carotid artery, carotid artery and 
sternal notch (to represent the top of the aortic arch) and 
sternal notch and posterior tibial artery, were measured as 
straight lines between those points on the body surface 
using an anthropometric tape measure. The pulse wave 
transit time was calculated using the R wave of the 
simultaneously recorded ECG as the point of cardiac 
ejection, and the arrival of the systolic pulse at the distal 
site, using the tonometer. The time taken between cardiac 
ejection and pulse arrival represented the pulse wave transit 
time. After manual entry of distances the software 
calculated PWV (m.s-1) as distance (m) divided by pulse 
wave transit time (s) (O'Rourke et al., 2002).  Measures 
were taken in triplicate at the different sites and the mean 
recorded. The intra-individual CV for the PWV 
measurement in our laboratory is 3.6 % for brachial 
(carotid to radial) PWV and 6.0 % for aortic (carotid to 
ankle) PWV.  
 
Functional Microvascular Reserve (FMR) 
The maximal hyperemic response to a local heat stimulus 
was determined using a single point laser Doppler flow 
meter probe (Pf2; Perimed) in accordance with previous 
studies in our laboratory (Middlebrooke et al., 2005; 
Middlebrooke et al., 2006) and is described in detail 
elsewhere (Rayman et al., 1986). In brief, a thermocouple 
was attached to the dorsal site of the foot immediately 
adjacent to the heating site. The foot was then gently 
warmed to 36°C before being heated to 42°C using a small 
brass heater (Shore et al., 1991). In order to reduce the 
burden on the participants the typical heating phase of 30 
minutes was reduced by 10 minutes. A 20 minute heating 
period has been shown to be sufficient in inducing 
maximum hyperaemia (Gooding et al., 1999) and has 
previously been used to determine maximal hyperaemia in 
young participants (Goh et al., 2001). With the heater 
remaining in situ, erythrocyte flux was measured at eight 
adjacent sites within the heated area, for 30 seconds at each 
site. The final value was calculated as the mean of the eight 
sites, measured in volts and used for later analysis in line 
with previous work (Middlebrooke et al., 2005; 
Middlebrooke et al., 2006). The mean intra-individual CV 
for FMR was 11.1 %.  
 
Iontophoresis of acetylcholine (ACh) and sodium 
nitroprusside (SNP) 
Iontophoresis was used in combination with laser Doppler 
perfusion imaging in order to investigate the vasodilatory 
response of the microcirculation to endothelial dependent 
(ACh) and independent (SNP) stimuli. The protocol 
outlined below has been described previously in detail 
(Middlebrooke et al., 2005; Middlebrooke et al., 2006; 
Stone et al., 2009) and has been developed within our 
laboratories over a number of years in order to elicit 
maximal drug delivery.  
Prior to iontophoresis assessment, the volar aspect 
of the right forearm of the participant was thoroughly 
cleaned.  The iontophoresis chambers (Moor Instruments 
Ltd., Devon, UK), consisting of a Perspex® ring with an 
internal diameter of 10 mm, were firmly secured to an area 
of forearm free from hair (where possible), freckles and 
broken skin using a double-sided adhesive ring. A 
conductive hydro-gel pad (Moor Instruments Ltd., Devon, 
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UK) was attached to the right wrist, which served as a 
reference or ‘indifferent’ electrode, in order to complete 
the electrical circuit.  Both the chamber and the indifferent 
electrode were connected to an iontophoresis controller 
(DRT4; Moor Instruments Ltd, Axminster, UK). 
For each test, solution was administered into the 
centre of the appropriate chamber with a glass cover slip 
placed on top. A laser Doppler imager (PIM II LDI; Lisca 
Development AB, Linköping, Sweden) was used to assess 
erythrocyte flux (in response to the iontophoretically 
introduced substance) at a distance of 130 mm from the 
region of interest on the skin surface.  A non-reflective 
cloth was placed over the laser head and test site in order 
to reduce the interference of external light on the 
measurements. 
Prior to the assessment of drug perfusion a vehicle 
response was obtained for each drug with 3% mannitol 
(RD&E Hospital, Devon, UK) and 0.45% saline (Fresenius 
Kabi Ltd., Warrington, UK). Following assessment of 
vehicle responses, a solution of 1% ACh (20 mg 
acetylcholine chloride and 60 mg mannitol in 2 mL of 
distilled deionised water; Novartis Pharmaceuticals UK 
Ltd., Surrey, UK) was delivered using a anodal (positive) 
charge with five doses (100 μA) for 20 seconds with a 60 
second interval between each dose, resulting in a total 
charge of 10 mC over the skin. Forearm skin erythrocyte 
flux was recorded immediately prior to the first charge 
(baseline), at the onset of each charge, and then 20 seconds 
after the end of each charge period resulting in a total of 12 
scans. 
SNP (0.25%; Mayne Pharma Plc., Warwickshire, 
UK) was delivered using a cathodal (negative) charge with 
one dose (200 μA) for 60 seconds, followed by five 
minutes of zero charge resulting in a total charge of 12 mC 
over the skin. Forearm skin erythrocyte flux was measured 
by a single perfusion image immediately prior to the first 
charge (baseline) and then every 60 seconds for six 
minutes, resulting in a total of seven scans.  
Data were expressed as the forearm skin red blood 
cell flux over an area of 0.78 cm2. A typical response to the 
iontophoresis delivery of ACh and SNP in two different 
participants is illustrated in Figure 1, both demonstrating a 
plateau in flux representative of a maximal vasodilatory 
response. The responses to ACh and SNP were expressed 
as peak response and area under the curve (AUC) 
respectively, measures which we have previously shown to 
represent endothelial dependent and independent function 
(Middlebrooke et al., 2005; Middlebrooke et al., 2006; 
Stone et al., 2009). The mean intra-individual CV for the 
peak response and AUC in our laboratory is 15.0 % and 
18.5 % for ACh and 13.1 % and 25.9 % for SNP 
respectively, and compare favorably with previous work of 
ours (Middlebrooke et al., 2006; Morris et al., 1995) and 
that of others (Puissant et al., 2013). 
 
Blood markers of CVD risk 
A trained clinician drew fasting venous blood samples after 
all vascular measurements had been completed. Sixteen 
children did not give blood samples since two refused 
assent at recruitment and an adequate sample could not be 
obtained from the remaining 14. Enzymatic assays were 
performed using a Roche modular analyser (Roche 
Diagnostics, Lewes, UK) in order to obtain measures of 
plasma glucose, total cholesterol, triglyceride (TG) and 
high density lipoprotein cholesterol (HDL-C), while low 
density lipoprotein cholesterol (LDL-C) was calculated 
using the Friedewald formula (Friedewald et al., 1972).  
Insulin was measured using a specific 
immunoenzymometric assay calibrated against 
International Reference Preparation 66/304 and with no 
detectable cross-reactivity with intact proinsulin or 32-33 
split proinsulin. An Excel version of the homeostatic model 
assessment (HOMA) calculator (version 2.2) was used to 
calculate β-cell function, insulin sensitivity (HOMA-IS) 
and insulin resistance (HOMA-IR) (OCDEM, 2004). The 
CV for glucose is 1.8 %, for total cholesterol 2.3 %, for TG 
2.9 %, for HDL-C 2.2 %, while the interassay CV for 
specific insulin is less than 10 % over the range 95 to 1038 
pmolꞏL-1. 
 
 
 
  
 
 Figure 1. Typical erythrocyte response to ACh (top graph) 
and SNP (bottom graph).  
 
Statistical analyses 
Statistical analyses were performed using SPSS for 
Windows (version 21; SPSS, Chicago, IL, US). Data are 
expressed as mean ± standard deviation unless stated 
otherwise. Data that were not normally distributed were 
log-transformed (visceral fat volume/total volume ratio, 
carotid-radial PWV, carotid-ankle PWV, total cholesterol, 
LDL-C, TG, specific insulin, β cell function, HOMA-IS 
Farr et al.
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and HOMA-IR) for analyses, but non-transformed 
descriptive data are presented for ease of interpretation. 
Sex differences in body composition, blood markers, peak 
V̇O2 and micro and macrovascular function were assessed 
using independent sample Student t tests. Pearson’s 
correlation coefficient was used to examine the association 
between measures of body composition (i.e. BMI, TBF%, 
VAT) and vascular and blood markers for the whole group 
and boys and girls separately. Pearson’s correlations were 
also used to investigate the relationship between peak V̇O2 
(ratio scaled to FFM and allometrically scaled to body 
mass) and measures of macro and microvascular function. 
Sex-specific quartiles for peak V̇O2 allometrically scaled 
for body mass (mL.kg-0.61.min-1) and ratio scaled for FFM 
(mL.FFM-1.min-1) were calculated to form ‘higher’ and 
‘lower’ aerobic fitness groups using a median split (i.e. 
quartile 1&2 vs quartile 3&4). Univariate analyses of 
variance (ANOVAs) compared mean differences in the 
vascular and blood outcomes between the aerobic fitness 
groups after adjusting for body composition if required. 
Specifically, where a significant correlation between a 
measure of body composition and the vascular or blood 
markers were identified, this was entered as a covariate into 
the ANOVA model. Statistical significance was set at an 
alpha level of 0.05. 
Results 
 
The physical and aerobic fitness characteristics of the 96 
children are displayed in Table 1. There were no 
differences between girls and boys for age, stature, body 
mass, BMI, VAT or VAT:total volume ratio. TBF% was 
greater in girls compared to boys. Of the 96 children, four 
were classified as obese (three girls) and nine classified as 
overweight (seven girls). Boys had a higher peak V̇O2 
compared to girls when expressed in absolute terms and 
when scaled for body mass (mLꞏkg-0.61ꞏmin-1) and FFM 
(mL.FFM-1ꞏmin-1).  
The vascular and blood outcomes are displayed in 
Table 2. There were no significant sex-differences for the 
vascular and blood outcomes.    
 
Body composition and vascular outcomes 
When assessed as a whole group and in both boys and girls 
separately there was a negative correlation between BMI 
and carotid to ankle PWV in the whole group  (r = -0.24; p 
= 0.020) and boys (r = -0.30; p = 0.038) but not girls (r = -
0.24; p = 0.13). Positive correlations were observed 
between TBF% and both peak SNP response (r = 0.33; p = 
0.008) and SNP AUC (r = 0.332; p = 0.008) for the whole 
group,  which  remained  in  boys (r = 0.36; p = 0.028 and
 
      Table 1. Anthropometric and exercise test characteristics. Values are mean ± SD 
 Whole Group (n=96) Boys (n=53) Girls (n=43) P-value 
Age (y) 9.9 ± 0.4 9.9 ± 0.3 9.9 ± 0.4 0.66 
Stature (m) 1.39 ±0.08 1.38 ±0.06 1.39 ±0.09 0.70 
Body mass (kg) 33.4 ±6.9 32.9 ± 5.0 34.1 ±8.8 0.42 
BMI (kgꞏm-2) 17.2 ±2.4 17.1±1.9 17.4± 2.9 0.73 
TBF% 17.9 ± 8.4 (n=86) 15.7 ± 8.2 (n=50) 21.0 ± 7.9 (n=36) 0.003 
VAT (cm3) 120.2 ± 75.9 (n=86) 117.6 ± 69.0 (n=49) 123.6 ± 85.0 (n=37) 0.72 
VAT as a % of total volume 4.70 ± 1.84 (n=86) 4.64 ± 1.75 (n=49) 4.78 ± 1.98  (n=37) 0.73 
Peak oxygen uptake (L.min-1)  1.37 ± 0.28 1.45 ± 0.25 1.27 ± 0.29 0.001
Peak oxygen uptake (mL.kg-0.61.min-1) 160.6 ± 28.5 171.7 ± 26.5 147.1 ± 25.1 <0.001
Peak oxygen uptake (mL.FFM-1.min-1) 50.7 ± 8.2 (n=86) 52.5 ± 8.4 (n=49) 48.2 ± 7.3 (n=37) 0.015
Sample size (n=) is provided when different from the whole group. Significant p values are highlighted in bold. BMI - body mass index; TBF% 
- total body fat percentage; VAT - visceral adipose tissue; FFM – fat free mass.  
 
Table 2. Vascular and blood characteristics. Values are mean ± standard deviation. 
  Whole Group Boys Girls 
Macrovascular 
PAI (%)  49.3 ± 9.9 (n=93) 48.2 ± 9.6 (n=50) 50.5 ± 10.2 (n=43) 
Carotid to ankle PWV (m.s-1) 5.97 ± 0.46 (n=90) 5.94 ± 0.46 (n=50) 6.02 ± 0.47 (n=40) 
Carotid to radial PWV (m.s-1) 6.64 ± 0.74 (n=94) 6.59 ± 0.66  (n=52) 6.70 ± 0.83  (n=42) 
Microvascular 
FMR (V) 1.78 ± 0.37 (n=96) 1.78 ± 0.32 (n=53) 1.79 ± 0.44(n=43) 
Peak ACh response (V) 1.96 ± 0.42 (n=93) 1.97 ± 0.46 (n=51) 1.95 ± 0.37 (n=42) 
ACh AUC (V x time) 479.6 ± 132.1 (n=92) 488.5 ± 140.2 (n=50) 469.1 ± 122.5 (n=42) 
Peak SNP response (V) 1.62 ± 0.49 (n=69) 1.65 ± 0.48 (n=38) 1.59 ± 0.51 (n=31) 
SNP AUC (V x time) 285.9 ± 113.6 (n=69) 291.6 ± 112.8 (n=38) 278.9 ± 115.9 (n=31) 
Blood 
Total cholesterol (mmol.L-1) 4.50 ± 0.46 (n=79) 4.53 ± 0.66 (n=49) 4.47 ± 0.47 (n=30) 
HDL-C (mmol.L-1) 1.86 ± 0.42 (n=78) 1.89 ± 0.44 (n=49) 1.80 ± 0.39 (n=29) 
LDL-C (mmol.L-1) 2.29 ± 0.59 (n=78) 2.28 ± 0.55 (n=49) 2.30 ± 0.66 (n=29) 
TG (mmol.L-1) 0.80 ± 0.29 (n=79) 0.77 ± 0.29 (n=49) 0.84 ± 0.30 (n=30) 
Glucose (mmol.L-1) 4.33 ± 0.42 (n=80) 4.32 ± 0.40 (n=49) 4.35 ± 0.36 (n=31)  
Specific insulin (pmol.L-1) 48.0 ± 25.0 (n=77) 44.2 ± 24.1 (n=46) 53.6 ± 25.6 (n=31)  
β-cell function (%) 124.5 ± 45.6 (n=77) 117.4 ± 45.7 (n=46) 135.0 ± 44.1 (n=31)  
HOMA-IS (%) 141.2 ± 87.1 (n=77) 153.0 ± 90.1 (n=46) 123.7 ± 80.6 (n=31)  
HOMA-IR 0.98 ± 0.51 (n=77) 0.90 ± 0.48 (n=46) 1.09 ±  0.52 (n=31) 
Values are mean ± standard deviation. Sample size (n=) is provided for each outcome. PAI - peripheral non-transformed augmentation index; PWV - 
pulse wave velocity; FMR - functional microvascular reserve; ACh - acetylcholine; AUC - area under the curve; SNP - sodium nitroprusside; HDL-C 
- high density lipoprotein cholesterol; LDL-C – low density lipoprotein cholesterol; TG -Triglyceride; HOMA – Homeostatic model assessment; IS – 
Insulin sensitivity; IR – Insulin resistance. 
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 r = 0.34; p = 0.038) and girls (r = 0.40; p = 0.045 and r = 
0.045; p = 0.022) respectively, when analysed separately. 
There were no other significant correlations between 
indices of body composition and vascular function in the 
group.  
There was a significant negative relationship 
between the volume of VAT and FMR (r = -0.23; p = 
0.031) for the whole group, but not when split by sex. 
There were no other significant correlations between the 
volume of VAT and the vascular outcomes.  
 
Body composition and blood outcomes 
Correlations between BMI and LDL-C (r = 0.26; p = 
0.020), TG (r = 0.31; p = 0.005), glucose (r = 0.23; p = 
0.040), specific insulin (r = 0.24; p = 0.039), HOMA-IS (r 
= -0.25; p = 0.032) and HOMA-IR (r = 0.25; p = 0.026) 
were apparent in the whole group. In boys, BMI was 
correlated with LDL-C (r = 0.35; p = 0.013).  In girls, BMI 
was correlated with TG (r = 0.44; p = 0.014), specific 
insulin (r = 0.42; p = 0.018), HOMA-IS (r = -0.41; p = 
0.022) and HOMA-IR (r = 0.421; p = 0.018).   
TBF% correlated with specific insulin (r = 0.41; p 
< 0.001), beta cell function (r = 0.37; p = 0.002), HOMA-
IS (r = -0.42; p < 0.001) and HOMA-IR (r = 0.41; p < 
0.001) for the whole group. In boys, TBF% was correlated 
with LDL-C (r = 0.29; p = 0.048); specific insulin (r = 
0.440; p < 0.001), beta cell function (0.42; p = 0.005), 
HOMA-IS (r = -0.45; p = 0.003) and HOMA-IR (r = 0.45; 
p = 0.003). No significant correlations were observed 
between TBF% and the blood outcomes in girls.  
The volume of VAT was not related to any of the 
blood outcomes apart from a significant positive 
association with TG in girls only (r = 0.47, p = 0.014).   
 
Aerobic fitness and vascular outcomes 
There were no significant correlations between the 
expressions of aerobic fitness and any of the macro and 
microvascular outcomes. Likewise, when split into higher 
and lower groups of aerobic fitness, no significant 
differences were found for the majority of the vascular 
outcomes (Table 3). However, the group with a higher peak 
V̇O2 scaled for body mass did have a higher (p < 0.05) 
carotid to ankle PWV, although this became non-
significant when peak V̇O2 was scaled for FFM.  
 
Aerobic fitness and markers of CVD risk 
There were no significant relationships for aerobic fitness 
and blood outcomes for the whole group and females. 
However, significant (p < 0.05) relationships were found for 
peak V̇O2 normalised for FFM (mL.FFM-1.min-1) and insulin 
markers [specific insulin (r = 0.34), β-cell function  (r = 0.38), 
HOMA-IS (r = - 0.32) and HOMA-IR (r =  0.31)] of metabolic 
health in boys only. In addition, significant negative 
relationships were found for peak V̇O2 and TBF% for the 
whole  group  (r = 0.34;  p = 0.001)  and girls (r = 0.34; p 
= 0.044,  but   these   disappeared  when   peak   V̇O2   was 
 
 Table 3. Macro and micro-vascular function by higher and lower aerobic fitness groups. Mean ± standard deviation. 
 Peak oxygen uptake 
(mL.kg-0.61.min-1) 
Peak oxygen uptake 
(mL.FFM-1.min-1) 
Lower Higher Lower Higher 
Macrovascular  
PAI (%) 51.1±9.5 (n=46) 47.5±10.1 (n=47) 49.1±10.6 (n=41) 49.4±9.5 (n=52) 
Carotid to ankle PWV (mꞏs-1) 5.87±0.43 (n=45) 6.08±0.47* (n=45) 5.93±0.43 (n=40) 6.02±0.49 (n=50) 
Carotid to radial PWV (mꞏs-1) 6.62±0.72 (n=48) 6.66±0.78 (n=46) 6.58±0.63 (n=42) 6.68±0.83 (n=52) 
Microvascular  
FMR (V) 1.77±0.36 (n=48) 1.80±0.39 (n=48) 1.76±0.35 (n=43) 1.81±0.40 (n=53) 
Peak ACh response (V) 1.95±0.45 (n=48) 1.97±0.40 (n=45) 1.88±0.46 (n=40) 2.02±0.38 (n=53) 
ACh AUC (V x time) 478.3±141.3 (n=44) 480.8±124.5 (n=48) 458.4±130.5 (n=39) 495.2±132.3 (n=53)
Peak SNP response (V) 1.64±0.49 (n=35) 1.57±0.50 (n=28) 1.54±0.46 (n=34) 1.69±0.53 (n=29) 
SNP AUC (V x time) 289.4±116.9 (n=35) 274.5±111.9 (n=28) 264.6±116.0 (n=34) 304.1±109.9 (n=29)
Sample size (n=) is provided for each outcome. PAI - peripheral non-transformed augmentation index; PWV - pulse wave velocity. FMR - functional 
microvascular reserve; ACh - acetylcholine; AUC - area under the curve; SNP - sodium nitroprusside.  Body mass index was entered as a covariate for 
carotid to ankle PWV. TBF% was added as a covariate for the SNP peak and AUC variables. * p < 0.05. 
 
Table 4. Cardiovascular disease risk outcomes by higher and lower aerobic fitness groups. Mean ± standard deviation. 
 Peak oxygen uptake 
(mL.kg-0.61.min-1) 
Peak oxygen uptake 
(mL.FFM-1.min-1) 
Lower Higher Lower Higher 
BMI (kgꞏm-2) 17.8 ± 2.9 (n=48) 16.8 ± 1.6 (n=48) 17.4  ± 2.38 (n=43) 17.1 ± 2.43 (n=53) 
TBF% 19.5 ± 9.6 (n=43) 16.2 ± 6.7 (n=43) 16.2 ± 8.7 (n=43) 19.6 ± 7.8 (n=43) 
VAT (cm3) 131.1 ± 86.4 (n=42) 109.8 ± 63.6 (n=44) 118.0 ± 60.2 (n=38) 121.9 ± 86.9 (n=48) 
Total cholesterol (mmolꞏL-1) 4.57 ± 0.66 (n=38) 4.45 ± 0.73 (n=41) 4.39 ± 0.63 (n=37) 4.61 ± 0.74 (n=42) 
HDL-C (mmolꞏL-1) 1.86 ± 0.44 (n=38) 1.86 ± 0.41 (n=40) 1.79 ± 0.40 (n=37) 1.92 ± 0.44 (n=41) 
LDL-C (mmolꞏL-1) 2.34 ± 0.59 (n=38) 2.24 ± 0.60 (n=40) 2.24 ± 0.55 (n=37) 2.33 ± 0.63 (n=41) 
TG (mmolꞏL-1) 0.81 ± 0.31 (n=38) 0.79 ± 0.28 (n=40) 0.78 ± 0.32 (n=37) 0.81 ± 0.28 (n=41) 
Glucose (mmol.L-1) 4.38 ± 0.33 (n=38) 4.29 ± 0.42 (n=42) 4.37 ± 0.38 (n=37) 4.30 ± 0.39 (n=43) 
Specific insulin (pmolꞏL-1) 45.1 ± 24.3 (n=35) 51.0 ± 25.7 (n=34) 43.4 ± 21.9 (n=36) 53.1 ± 27.5 (n=33) 
β-cell function (%) 118.1 ± 44.7 (n=35) 130.4 ± 47.5 (n=34) 113.2 ± 35.2 (n=36) 136.2 ± 53.8 (n=33) 
HOMA-IS (%) 153.7 ± 98.9 (n=35) 127.0 ± 71.9 (n=34) 157.3 ± 101.3 (n=36) 122.4 ± 65.0 (n=33) 
HOMA-IR 0.92 ± 0.49 (n=35) 1.04 ± 0.51 (n=34) 0.89 ± 0.45 (n=36) 1.07 ± 0.55 (n=33) 
Sample size (n=) is provided for each outcome. BMI - body mass index; TBF% - total body fat percentage; VAT - visceral adipose tissue; HDL-C - high 
density lipoprotein cholesterol; LDL-C – low density lipoprotein cholesterol; TG -Triglyceride; HOMA – Homeostatic model assessment; IS – Insulin 
sensitivity; IR – Insulin resistance. TBF% was entered as a covariate for the specific insulin, β-cell function, HOMA-IS and HOMA-IR outcomes.   
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 normalised for FFM. ANOVA analyses did not reveal any 
mean differences between aerobic fitness groups for any of 
the markers of CVD risk (see Table 4), with TBF% entered 
as a covariate for the specific insulin, beta cell function, 
HOMA-IS and HOMA-IR models.  
 
Discussion 
 
The aim of the current study was to investigate whether a 
higher level of aerobic fitness, after appropriate adjustment 
for body size and composition, is related to improved 
macro and microvascular health and CVD risk in children. 
Our key finding was that higher levels of aerobic fitness, 
irrespective of normalisation for body mass or FFM, was 
not associated with improved vascular or CVD risk health 
outcomes in our sample of 9-10 year old children.    
In contrast to our primary hypothesis, there was no 
consistent evidence for differences in macrovascular 
outcomes between the higher and lower aerobic fitness 
groups. However, children who had a higher aerobic fitness 
when allometrically scaled for body mass exhibited a 
higher carotid to ankle PWV compared to the lower fitness 
group. These observations are contrary to previous work 
which has shown that aerobic fitness exerts a positive 
effect on large artery compliance in children (Agbaje et al., 
2019; Reed et al., 2005; Veijalainen et al., 2016), 
adolescents (Haapala et al., 2018) and young adults 
(Boreham et al., 2004). Interestingly, Meyer and colleagues 
(2017) reported a similar finding to the current paper in that 
brachial artery PWV was associated with higher aerobic 
fitness in 646 children and adolescents. They 
acknowledged the inverse relationship between aerobic 
fitness and arterial stiffness in older subjects but 
commented that much of the literature reporting the same 
association in young children is controversial since results 
are mediated by fat intake, stature, blood pressure and most 
notably body fat. Our findings that BMI and TBF% 
correlated with carotid to ankle PWV and (endothelial 
independent) SNP responses respectively, support an 
influence of body composition on vascular function in 
young subjects. Of note is that the difference in carotid to 
ankle PWV between the higher and lower fitness groups in 
the current study was no longer significant when aerobic 
fitness was adjusted for FFM, thus providing further 
evidence for an affect of body composition on 
macrovascular outcomes.      
Previous studies have suggested that the beneficial 
effects of aerobic exercise may begin further down the 
vascular tree with greater aerobic fitness associated with 
improved microcirculatory function (Reed et al., 2005). 
However, the results of the current study do not support 
this suggestion since no associations were apparent 
between microvascular function and aerobic fitness, which 
is in agreement with a previous report in adolescents 
(Radtke et al., 2013). Thus our hypothesis that reduced 
aerobic fitness will be associated with a more impaired 
microvascular function cannot be supported, and these 
observations were consistent regardless of the scaling 
method employed to normalise peak V̇O2 for body size and 
composition. As associations between aerobic fitness and 
microvascular function have been shown in children and 
adolescents with type I diabetes (Roche et al., 2008), who 
have reduced aerobic fitness (Komatsu et al., 2005) and 
endothelial dysfunction, it may be that in our healthy 
cohort of young children the microcirculation in those with 
lower levels of aerobic fitness is not impaired. 
Alternatively, there may be other mediating factors such as 
maturity status, diet or levels of physical activity that could 
impact on vascular health and need to be taken into 
consideration in further studies in children. 
A second hypothesis of this study was to test 
whether those with a higher aerobic fitness would present 
reduced CVD risk. We found a negative association 
between TBF% and peak V̇O2 normalised for body mass in 
the whole group and girls, which disappeared when peak 
V̇O2 was scaled for FFM. In addition, in boys only, we 
found significant associations between specific insulin, β-
cell function, insulin sensitivity and peak V̇O2 scaled for 
FFM. However, when the whole group was split into 
higher and lower groups for aerobic fitness and adjustment 
made for TBF%, no differences in insulin health outcomes 
were observed. Thus, the present study found no consistent 
evidence for superior CVD risk factor status in children 
with higher aerobic fitness. Evidence supporting a direct 
association between aerobic fitness and CVD risk in 
children and adolescence within the literature is 
inconclusive. While some groups have reported 
associations between increased aerobic fitness and lower 
individual and clustered CVD risk (Ekelund et al., 2007; 
Latt et al., 2016) and increased insulin sensitivity (Lee et 
al., 2006; Ruiz et al., 2007), the relationships are either 
mediated or confounded by adiposity. Indeed, a recent 
meta-analysis of longitudinal studies investigating the 
relationship between aerobic fitness in youth and future 
CVD risk concluded that the relationships were 
unconvincing and stressed the importance of accounting 
for adiposity during analyses (Mintjens et al., 2018). The 
results of the current investigation further support the need 
to correctly adjust for adiposity in future work of aerobic 
fitness and CVD risk in youth.   
A major strength of this study is thus the direct 
determination of aerobic fitness (peak V̇O2) and 
normalisation for body size and composition using scaling 
procedures that resulted in a size-free expression of aerobic 
fitness. Many prior studies have used predictions of peak 
V̇O2 from performance measures (e.g. 20 m shuttle test), 
which are crude surrogate measures of aerobic fitness and 
have a residual relationship with body size/fatness. Even 
studies that have directly assessed peak V̇O2 have 
expressed peak V̇O2 as a ratio standard to body mass. Ratio 
scaling is known to 'overscale' and this method still holds 
a strong negative relationship with body size (Armstrong 
and McManus, 2017). A further strength of this study is the 
direct  assessment  of  visceral  adiposity, a  gold standard 
measure of body fat percentage and the inclusion of a 
number of vascular (macro and micro) measures.  
Although 96 children completed the study it was 
challenging to acquire some of the microvascular measures 
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in this population meaning the final data set was reduced 
to 69 for the peak SNP response and SNP AUC. Data for 
24 children were lost to technical error, two due to a poor 
laser signal and one child requested to stop the test early 
because of discomfort. We did however make every effort 
to ensure the rigor of the methods used in this study and 
have provided laboratory specific values for measurement 
variability for all our vascular measures. Furthermore, we 
did not measure physical activity in the current study which 
is known to be related to vascular health outcomes in youth 
independent of fitness (Radtke et al., 2013). We also did 
not undertake a formal measurement of pubertal status (i.e. 
pubertal stages) and the participants were referred to as 
nine to 10 year old children throughout the current paper.  
 
Conclusion 
 
The results of the current study revealed that higher levels 
of aerobic fitness, whether scaled for body mass or FFM, 
is not related to macro and microvascular health outcomes 
and CVD risk factors in 9-10 year old children. We 
hypothesise that this lack of an association between fitness 
and vascular and CVD risk health outcomes is due to the 
low exposure to the deleterious effect of lifestyle factors on 
altering the vasculature in children within the first decade 
of life. Thus, tracking of individuals from childhood to 
adulthood would be necessary to identify changes in large 
and small vessel outcomes and CVD risk with aerobic 
fitness over time. 
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Key points 
 
 Children with a greater aerobic fitness had a higher 
carotid to ankle PWV compared to the lower fitness 
group when scaled for body mass, but not when ad-
justed for FFM. 
 When split into higher and lower groups for aerobic 
fitness and adjusted for TBF%, no differences in CVD 
risk factors were observed.  
 Higher levels of aerobic fitness, irrespective of nor-
malisation for body mass or FFM, was not associated 
with improved vascular or CVD risk health outcomes 
in 9-10 year old children. 
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